10.51847/vNq2F0s

K.E. Tairova, Jh.R. Dilbarkhanova, Maria G. Rayisyan, Vladimir Dmitriyevich Sekerin, Anna Evgenievna Gorokhova

2000

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.51847/vnq2f0s
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article discusses ways to improve the regulatory system for medicine production in the Republic of Kazakhstan based on the study of regulatory documents governing the pharmaceutical business. The article aims to study the regulatory framework governing the pharmaceutical business and consider the prospects for the development of legal support for this industry. To achieve this goal, the authors have identified and achieved the following objectives: performing an analysis of Kazakh and foreig